A study co-authored by a Cornell economist reveals that Black Americans are more likely to participate in medical trials when led by Black professionals due to perceived trustworthiness. This suggests a need for leadership diversity in clinical trials to better represent underrepresented groups like Black Americans, who face significant health disparities. The researchers argue that adequate representation is crucial for understanding treatment effects across different populations, thereby improving healthcare services and outcomes for all. The study was published in the Journal of Health Economics.
Black Americans are more willing to participate in medical studies led by Black doctors and researchers, perceiving them as more trustworthy.
If clinical trials don't adequately represent all the populations that are going to use a drug, this may threaten the generalizability you would hope to have.
Collection
[
|
...
]